Rating History for 9/1/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| 10X Genomics
(RBC Capital - Dan Leonard) |
TXG | New Coverage | Sector Perform (N/A) |
70.00 (N/A) |
61.54 (88.50) |
43.81% | Details | ||
| Aclaris Therapeutis
(Canaccord - Edward Nash) |
ACRS | New Coverage | Buy (N/A) |
10.00 (N/A) |
6.05 (5.43) |
-10.25% | Details | ||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 247 more... | |||||||||
